Using Cells for Healing
Autologous cell therapies and a dermal injection device, in development.
View programs
About RepliCel
RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.
All of RepliCel’s programs are in development.
About the companyAutologous cell therapy
The cell therapies RepliCel is developing use a patient’s own cells.
Tissue sample
A small tissue sample is taken from the back of the patient’s scalp.
Isolation
Cells are isolated from hair follicles in the sample.
Expansion
The cells are expanded in culture.
Injection
The patient’s own cells are injected back into the same patient.
Programs
Four programs. All are in development.
DermaPrecise™
A motorized dermal injection device with programmable injection depth and volume. In development.
About DermaPrecisePublications
Peer-reviewed papers, posters and company documents related to RepliCel’s programs.
View publications